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The question as to when is the right time to operate on adilated ascending aorta has not yet been definitivelyanswered. In cases of rupture or a Stanford type Adissection, operative intervention provides the only
chance for the patient to survive. In cases of increased aortic size,
the indication for surgery or follow-up needs a standardized pro-
cess that takes into account all available patient data. Currently,
however, there is not complete agreement as to which criteria to
use to solve this problem. By calculating the right time for elective
surgery, when the operative risk is lower than the risk of dilation-
related complications, it could be ideally possible to avoid urgent
surgical procedures on the ascending aorta. For this reason, a
simple and quick method to determine the correct operative timing
on the basis of clinical and echocardiographic findings would be
useful to the surgeon. Currently, the size of the aorta and the
underlying aortic pathologic process1-3 are considered the most
important factors in predicting complications. The aim of this
study is to move from the current criteria of indication for aortic
surgery (the mean cutoff diameter) to a standard method of indi-
cation for elective surgery with echocardiographic measurements
and few simple data obtained from the individual patient’s clinical
history. To reach this goal, we reviewed the literature data in a
synthesis and then developed a new formula.
Methods
To define the “normal” size of the aorta, we stratified the measures
on the basis of sex and age. The chosen approach for visualization
was 2-dimensional echocardiography, because it is the routine
diagnostic imaging for the ascending aorta. The wide set of healthy
individual data from Roman and colleagues4 was used, including
data from 52 healthy infants and 135 healthy adults. Echocardi-
ography was performed with the patient in the left decubitus
position, marking up to 6 cycles of the aortic root and left ventri-
cle.4,5 In Roman and colleagues’ series,4 sizes were obtained at
four levels: annulus, sinuses of Valsalva, supra-aortic ridge, and
proximal ascending aorta. For our study, we referred to the supra-
aortic ridge level. Measurements were made perpendicular to the
long axis of the aorta with the leading-edge technique in views
showing the largest aortic diameters. Approximate 95% normal
confidence intervals were derived as 2 SEs of the estimate for
aortic root dimensions above and below the regression line of the
variable with body size. In Roman and colleagues’ population,4
these confidence intervals encompassed 350 of 359 data points
(97%), whereas only 2 of 359 (0.6%) of values from healthy
subjects fell above normal limits. Although gender, blood pressure,
and stroke volume are significant correlates of aortic root dimen-
sions, body size and age appear to be the primary independent
determinants of aortic size in healthy people. Upper 95% normal
confidence limits of aortic root diameters (expressed in centime-
ters) at the supra-aortic ridge (SR95%) are presented in the fol-
lowing formulas:
1. Infants and children: SR95%  1.21  0.8  BSA.
2. Adults younger than 40 years: SR95%  1.48  0.82 
BSA.
3. Adults older than 40 years: SR95%  2.35  0.62  BSA.
SR95% was considered, in the following steps, to represent the
predicted diameter (PD); that is, the higher normal value for the
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Figure 1. Calculated risks of complications in patients older than
40 years with 1.75 m2 BSA and Marfan, bicuspid aortic valve, and
generic underlying pathologic conditions.
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patient of a given age and body surface area (BSA). PD includes
95% of normal aortic size for a given BSA in a cluster of age-
stratified patients.
Once we had defined the PD, we searched for a mathematic
relationship among it, the diameter measured by echocardiogra-
phy, and the risk of rupture or Stanford type A dissection. Ergin
and associates6 in the Aortic Surgery Symposium VI (Mount Sinai
Medical Center, New York, 1998), dealing with timing of indica-
tion for elective surgical treatment of the dilated ascending aorta,
noted the following: (1) Magnitude of the risk for spontaneous
rupture or dissection is closely related to the aortic ratio (measured
diameter MD/PD). (2) The cutoff aortic ratio varies according to
the underlying pathologic process of the aortic wall. They sug-
gested considering the risk the same for an aortic ratio of 1.3 in
patients with Marfan syndrome (with familial history) and in
patients with chronic dissection, for 1.4 in patients with bicuspid
valve with dysfunction, and for 1.5 in patients with other condi-
tions. Moreover, Legget and colleagues7 suggested that patients
with aortic dimensions smaller than these values of aortic ratio
could be observed at follow-up, delaying surgery. In addition, they
showed that a ratio of 1.3 in Marfan syndrome increases the risk of
complication by 2.7, thus adding a quantitative measurement of the
risk.
Results
On the basis of previous data, we traced an exponential curve with
calculated risk of rupture or dissection (R) on the y-axis and the
ratio (MD  PD)/MD on the x-axis. This ratio is positive in cases
of increased aortic ratio, equal to 0 in cases of an aortic ratio of 1
(PD  MD), and negative in cases of MD lower than PD (Figure
1). When MD is equal to PD, R is 1; it rapidly increases on the
right side of the curve (MD PD) and slowly decreases on the left
side (MD  PD). In this formula, we introduced a coefficient (C)
to give the R value an unique significance in the presence of
different underlying pathologic processes. This coefficient was
computed as the ratio MD/(MD  PD), the inverse of (MD 
PD)/MD. Because critical aortic ratio (MD/PD) assumes different
values according to Ergin and associates,6 for Marfan and chronic
dissection (MD/PD 1.3) the value of C is 4.3, for bicuspid aortic
valve (MD/PD  1.4) C is 3.5, and for other conditions (MD/PD
 1.5), C is 3.0. The following formula was defined:
R  eC  [MD-PD]/MD
where MD and PD are expressed in centimeters. We considered R
greater than 2.7 as a potential indication for surgery.7 For a
50-year-old patient with a BSA of 1.75 m2 and Marfan syndrome,
an R of 2.7 would correspond to 4.5 cm; in the case of generic risk,
it would correspond to 5.2 cm. We underscore that indication for
surgery begins just above these values; however, as suggested by
Ergin and associates,6 it should be taken into account to add as
much as 0.15 to the aortic ratio, on the basis of the surgeon’s
experience, in indicating surgery for an otherwise symptom-free
patient. That way we can quite safely consider the surgical option
when R is greater than 3. The operation should not be delayed if
the aortic size is higher than the critical aortic size, expressed as
the following:
Critical aortic size PD K
where K is 1.45 (1.3  0.15) in Marfan syndrome and chronic
dissection, 1.55 (1.4 0.15) in bicuspid aortic valve, and 1.65 (1.5
 0.15) in other conditions.
It is possible to reverse the calculation for any given level of
risk to determine what it means in terms of the size of the
supra-aortic ridge (MD):
MD
C  PD
C  lnR
where MD is the size of the supra-aortic ridge corresponding to the
risk, C is the pathology-related coefficient, PD is the PD for the
individual patient, and lnR is the natural logarithm of the risk to
evaluate.
TABLE 1. Features and results
Patient
MD
(cm)
PD
(cm) Risk
Operation
(yes/no)
Follow-up
(mo) Complications*
1 5.5 3.7 2.73 No 3 No
2 5.0 3.8 2.06 No 6 No
3 6.0 3.6 3.27 No† 3 No
4 5.0 3.4 3.80 Yes — No
5 6.3 3.5 3.81 Yes — No
6 7.0 3.4 4.65 Yes — No
7 4.0 3.1 2.51 No 6 No
8 4.5 3.6 1.82 No 12 No
9 4.0 3.6 1.39 No 12 No
10 4.1 3.5 1.89 No 12 No
11 5.0 3.8 2.83 No 3 No
12 4.6 3.5 2.8 No 3 No
13 4.6 3.3 3.43 Yes — No
14 4.3 3.4 2.00 No 12 No
15 4.5 3.4 3.00 Yes — No
*Complications as of September 30, 2001.
†The patient refused surgery.
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Application
On the basis of our formula, we prospectively studied the patients
who were referred to our center for isolated dilation of the ascend-
ing aorta during a 6-month period (April through September 2001).
Data from a total of 15 patients were collected, and the decision
making was based mainly on R value. Six patients with R values
of at least 3 were assigned to elective surgery, but 1 refused the
operation, choosing to undergo a new control after 3 months. The
other 9 patients were assigned to undergo echocardiographic fol-
low-up: after 3 months for R between 2.7 and 3, after 6 months for
R between 2.0 and 2.7, and after 12 months for R less than 2.0.
None of the 15 patients had any complications (Table 1).
Discussion
Isolated dilation of ascending aorta requires particular care in
identification of the critical size at which risk of rupture or dis-
section becomes greater then the risk of elective surgery. The
surgeon’s experience in aortic root surgery remains an important
factor but cannot represent the only determinant in the statement of
timing. At present, one of the most used criteria to evaluate a
dilated ascending aorta is based on the rate of aneurysm dilata-
tion.1,6-11 This parameter, which describes the increase of the
diameter of ascending aorta in serial assessment, is related to the
chance of complications (an increase greater than 5%/y in the
aortic ratio in a patient with Marfan syndrome leads to an increase
in the risk of complications by a factor of 4.1).6 However, the need
for consecutive determinations makes this approach less than
useful in estimation of immediate risk with a single measurement.
For patients with aortic dilation at the first echocardiography, a
“one time” prediction parameter should be available to help choose
between surgery and follow-up. On the basis of the R value, we
tried to estimate how often surveillance is necessary and when
surgery might be needed. To make the application of these issues
easier, a simple HTML page has been created; it includes a few
fields to fill in (age, height, weight, comorbidity) and calculates the
PD, the calculated risk (R), and the critical aortic size. This page
is available at www.aortaonline.org.
Although in a rational approach to the dilated ascending aorta
we must underscore the importance of interindividual variations
and the single institutional experience (making it difficult to create
an absolute definition of risk), we believe that a personalized
profile of risk is better than the traditional mean cutoff. We are
using this formula now in our routine clinical setting, with encour-
aging results. To determine more quantitative criteria for these
important issues, we suggest a prospective approach that uses our
formula for the indication for elective surgery of the dilated
ascending aorta in clinical practice, ideally collecting the data in a
multicenter study.
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